Helicobacter pylori and clinical aspects of gastric cancer

Helicobacter

Volumn 14, Issue SUPPL. 1, 2009, Pages 41-45

  Bornschein, Jan ^a   Rokkas, Theodore ^b   Selgrad, Michael ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HENRY DUNANT HOSPITAL   (Greece)

Author keywords

Cost effectiveness; D2 lymphadenectomy; Endoscopic resection; Eradication; Gastric cancer; Glandular atrophy; H. pylori; Intestinal metaplasia; Prevention strategies; Screening; Therapy

Indexed keywords

AMOXICILLIN; CISPLATIN; CLARITHROMYCIN; DOCETAXEL; LANSOPRAZOLE;

CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; ENDOSCOPIC MUCOSAL RESECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STOMACH CANCER; STOMACH ULCER; ULCER HEALING;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 69449096506     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00695.x     Document Type: Review

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74 108.
2. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquinali M, Berrino F. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003 5 (Suppl. 14 v128 49.
3. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van d V, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006 355 : 11 20.
4. Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg 2009 96 : 26 33.
5. Schonnemann KR, Jensen HA, Yilmaz M, Jensen BY, Larsen O, Pfeiffer P. Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer. Br J Cancer 2008 99 : 858 861.
6. Jung JY, Kwon JH, Kim JH, Song HH, Kim I, Lee KS, et al. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer. Oncol Rep 2009 21 : 523 529.
7. Lin RB, Fan NF, Guo ZQ, Wang XJ, Liu J, Chen L. A phase II study of 5-fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as first-line treatment for patients with advanced gastric cancer. J Chemother 2008 20 : 744 748.
8. Nagata N, Kimura M, Hirabayashi N, Tuburaya A, Murata T, Kondo K, et al. Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancer. Hepatogastroenterology 2008 55 : 1846 1850.
9. Emi Y, Yamamoto M, Takahashi I, Orita H, Kakeji Y, Kohnoe S, et al. Phase II study of weekly paclitaxel by one-hour infusion for advanced gastric cancer. Surg Today 2008 38 : 1013 1020.
10. Lee JJ, Kim SY, Chung HC, Lee KH, Song HS, Kang WK, et al. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer. Cancer Chemother Pharmacol 2009 63 : 1083 1090.
11. Park SR, Lee JS, Kim CG, Kim HK, Kook MC, Kim YW, et al. Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer 2008 112 : 2368 2376.
12. Nitti D, Marchet A, Mocellin S, Rossi GM, Ambrosi A, Mencarelli R. Prognostic value of subclassification of T2 tumours in patients with gastric cancer. Br J Surg 2009 96 : 398 404.
13. Zhang X, Tanigawa N, Nomura E, Lee SW. Curability of laparoscopic gastrectomy for gastric cancer: an analysis of 10 years' experience. Gastric Cancer 2008 11 : 175 180.
14. Kim W, Song KY, Lee HJ, Han SU, Hyung WJ, Cho GS. The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results. Ann Surg 2008 248 : 793 799.
15. An JY, Youn HG, Choi MG, Noh JH, Sohn TS, Kim S. The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg 2008 196 : 587 591.
16. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008 359 : 453 462.
17. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998 1 : 10 24.
18. Isomoto H, Shikuwa S, Yamaguchi N, Fukuda E, Ikeda K, Nishiyama H, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut 2009 58 : 331 336.
19. Song KY, Park SM, Kim SN, Park CH. The role of surgery in the treatment of recurrent gastric cancer. Am J Surg 2008 196 : 19 22.
20. Oda I, Gotoda T, Sasako M, Sano T, Katai H, Fukagawa T, et al. Treatment strategy after non-curative endoscopic resection of early gastric cancer. Br J Surg 2008 95 : 1495 1500.
21. Fuccio L, Zagari RM, Minardi ME, Bazzoli F. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007 25 : 133 141.
22. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004 291 : 187 194.
23. Watari J, Das KK, Amenta PS, Tanabe H, Tanaka A, Geng X, et al. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clin Gastroenterol Hepatol 2008 6 : 409 417.
24. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008 372 : 392 397.
25. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997 6 : 639 642.
26. Nakagawa S, Asaka M, Kato M, Nakamura T, Kato C, Fujioka T, et al. Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer. Aliment Pharmacol Ther 2006 24 (Suppl. 4 214 218.
27. Cheon JH, Kim JH, Lee SK, Kim TI, Kim WH, Lee YC. Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study. Helicobacter 2008 13 : 564 571.
28. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004 109 : 138 143.
29. de Vries AC, van Grieken NC, Looman CW, Casparie MK, de VE, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008 134 : 945 952.
30. Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005 54 : 1536 1540.
31. Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 2008 47 : 1077 1083.
32. Yeh JM, Kuntz KM, Ezzati M, Goldie SJ. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer 2009 124 : 157 166.
33. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008 103 : 510 514.